期刊文献+

心源性脑卒中患者血浆脑钠肽水平测定及其临床意义 被引量:5

The dinical significance of testing plasma brain natriuretic peptide(BNP) in cardioembolic stroke patients
原文传递
导出
摘要 目的探讨心源性脑卒中与血浆脑钠肽(BNP)的关系。方法收集81例急性脑卒中患者临床资料,按照TOAST分型,分为非心源性脑卒中,包括大动脉粥样硬化性、心源性、腔隙性、其他原因及原因不明脑卒中。入院24h内采集血样标本,采用ELISA方法测定血脑钠肽水平。比较心源性与非心源性脑卒中患者的血脑钠肽水平。结果心源性脑卒中患者的血浆BNP水平为(147.5±7.8)ng/L,动脉粥样硬化性卒中患者为(51.2±5.8)ng/L,腔隙性卒中患者为(39.5±10.0)ng/L。心源性脑卒中患者的血浆BNP水平显著高于非心源性脑卒中患者(t=67.8,23.6,17.6,均P〈0.01)。结论血浆BNP水平可用于鉴别心源性与非心源性脑卒中,其在脑卒中的病因学诊断中可能具有一定的临床意义。 Objective To study the relationship between cardioembolic stroke and plasma BNP by analyzing the plasma BNP level in cardioembolie stroke patients. Methods The clinical data of 81 patients with acute stroke were collected. According to the TOAST classification, all the patients were diagnosed as non-cardioembolic stroke,including atherothrombotic,lacunar, others etiology and undetermined etiology eardioembolic stroke. Blood samples were drawn on emergency department arrival(within 24 hours) to test BNP( assayed by ELISA). The plasma BNP level be- tween non-eardioembolic stroke and eardioembolic stroke was compared. Results Cardiogenic stroke patients with plasma BNP level ( 147.5 ± 7.8) ng/L, atherosclerotic stroke patients level (51.2 ±5.8 ) ng/L, lacunar stroke ( 39.5 ±10.0)ng/L. Higher levels of BNP were observed in patients with cardioembolie stroke than other stroke subtypes( t = 67.8,23.6,17.6, all P 〈 0.01 ). Conclusion The plasma BNP could be used for distinguishing cardioembolic stroke from other stroke subtypes and has great clinical significance in etiologic diagnosis of ischemie stroke subtypes.
出处 《中国基层医药》 CAS 2012年第4期493-494,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 心源性 卒中 脑钠肽 Cardioembolic stroke Bain natriuretic peptide
  • 相关文献

参考文献11

  • 1Adams HP Jr, Bendixen BH, Kappelle LJ, et al, Classification of subtype of acute ischemic stroke. Definitions for use in a multi- center clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 1993,24 ( 1 ) :35-41.
  • 2Kolominsky-Rabas PL, Weber M, Gefeller O, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: inci- dence, recurrence, and long-term survival in ischemic stroke sub- types:a population-based study. Stroke, 2001,32 ( 12 ) : 2735- 2740.
  • 3朱文洁.急性脑梗死患者脑钠肽变化及临床意义[J].中国临床医学,2008,15(3):310-311. 被引量:11
  • 4Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic Diagnosis of Ischemie Stroke Subtypes With Plasma Biomarkers. Stroke, 2008,39 ( 8 ) : 2280-2287.
  • 5Mikikallio AM, Makikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke, 2005,36 (5):1016- 1020.
  • 6Panteghini M. Role and importance of biochemical markers in clinical cardiology. Enr Heart J,2004,25 ( 14 ) : 1187-1196.
  • 7Shibazaki K, Kimura K, Iguchi Y, et al. Plasma brain natriuretic peptide can be a biological marker to distinguish cardioembolic stroke from other stroke types in acute ischemic stroke. Intern Med ,2009,48 (5) :259-264.
  • 8Zivin JA. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U. S. Food and Drug Admin- istration(FDA). Ann Neuro1,2009,66( 1 ) :6-10.
  • 9Haeke W, Kaste M, Bluhmki E, et al. Thrombolysis with aheplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med,2008, 359(13) :1317-1329.
  • 10吴雁.B型钠尿肽检测的临床应用[J].中国基层医药,2004,11(5):628-629. 被引量:3

二级参考文献22

  • 1王岚峰,吴双,关秀茹,沈景霞,薛凤华.脑钠素对心肌梗死急性期血管再通的早期诊断意义[J].中国介入心脏病学杂志,2005,13(5):333-334. 被引量:2
  • 2王蓉,李友元,杨宇.急性脑梗死患者血浆脑钠素水平变化及临床意义[J].中华老年医学杂志,2006,25(5):356-357. 被引量:22
  • 3Sang HL,Jae-HJ,Seung-H C,et al. Determinants of brainnatriuretic peptide levels in patients with long atrial fibrillation[J]. Circ J, 2006,70: 100-104.
  • 4Emanuele DA,Stefano DC,Danilo T, et al. Determinants of plasma levels of brain natriuretic peptide after acute ischemic strok or TIA [J]. Journal of the neurological Sciences, 2007,260:139-142.
  • 5Wikins MR, Redondo J ,Brown LA. The natriuretic peptid family [J]. Lancet, 1997,349:1307-1310.
  • 6Inoue S,Murakami Y,Sano K, et al . Atrium as source of brain natriuret-ic polypeptide in patients with atrial fibrillation [J]. Card Fail ,2000, 6 (2) :92-96.
  • 7Silvet H,Young-XY,Walleigh D, et al. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation[J]. Am J Cardiol,2003, 92:124-127.
  • 8Rashidi A. Mechanism of high natriuretic peptide in patients with atrial fibrillation[J]. Am J Cardiol,2004,93(5) :670.
  • 9Shimizu H,Murakami Y, Inoue S, et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation[J]. Stroke, 2002 ,33 (4):1005-1010.
  • 10Wallen T,Landahl S,Hedner T,et al.Brain natriuretic peptide in an elderly population[].Journal of Internal Medicine.1997

共引文献14

同被引文献31

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部